Guided Therapeutics Inc (GTHP)

[GetSeriousOK]

I don't think you can read about an SEC complaint unless the SEC files a case against the manipulator.

Something to watch for, I guess, but it might also be BS, considering the source. Remember, this is the guy who insisted the company didn't really have Officers other than the CEO, and the CEO was pocketing the money instead of using it to fund the clinical trials.

In a thinly traded ticker, MM's can do some sketchy things without breaking the law. They can legally dip down and take out stop losses, for example.

GTHP's catalysts are still in the distance. GTHP will be susceptible to manipulation for several more months, unless the Chinese Play (SMI) comes true, which, as I have stated many times, is probably just BS from SMI. The first phase of determining whether SMI is still blowing smoke will be the appearance of money on the books when/if SMI submits the application to the NMPA. They are SUPPOSED to order $2.1M worth of product upon that submission.

SMI has informed the Company that it expects to complete the clinical trial required to obtain NMPA approval by the middle of this year. Further, SMI expects to receive final regulatory approval to market in China by the end of this year. Under the Agreement, approximately $2.1 million of the purchase orders must be fulfilled by the time SMI files its application with clinical data to the NMPA. Approximately $570,000 is due at the time NMPA approval is obtained, and another $1.24 million is due by March 31, 2024.

We all know that it's unrealistic for SMI to promise that they will finish the trials by mid year and achieve approval by the end of the year. I don't blame GTHP for SMI's failures to achieve anything they promise because it's been such obvious BS. I don't expect SMI to fork over $2.1 million this year or EVER, but who knows, stranger things have happened.